Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-060293

CEO gave up 22,043 shares (to pay taxes)

  • CEO acquired 38,453 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gline Matthew CEO 2023-12-27 Option exercise 10b5-1 +38,453 1,044,941 D
Gline Matthew CEO 2023-12-27 Shares withheld for taxes 10b5-1 −22,043 $11.58 $255,258 1,022,898 D
Derivatives
Gline Matthew CEO 2023-12-27 Option exercise · Capped Value Appreciation Rights 10b5-1 −85,232 $6.40 $545,485 994,373 D
Gline Matthew CEO 2023-12-27 Option exercise · Capped Value Appreciation Rights 10b5-1 −47,351 $11.50 $544,537 2,178,150 D
Loading xslF345X05/form4.xml…